- Home
- DSGN vs STSS Comparison
DSGN vs STSS Comparison
Compare DSGN & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- STSS
- Stock Information
- Founded
- DSGN 2017
- STSS 2017
- Country
- DSGN United States
- STSS United States
- Employees
- DSGN N/A
- STSS N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- DSGN Health Care
- STSS Health Care
- Exchange
- DSGN Nasdaq
- STSS Nasdaq
- Market Cap
- DSGN 208.9M
- STSS 186.3M
- IPO Year
- DSGN 2021
- STSS 2022
- Fundamental
- Price
- DSGN $6.54
- STSS $6.31
- Analyst Decision
- DSGN
- STSS
- Analyst Count
- DSGN 0
- STSS 0
- Target Price
- DSGN N/A
- STSS N/A
- AVG Volume (30 Days)
- DSGN 173.8K
- STSS 1.0M
- Earning Date
- DSGN 11-06-2025
- STSS 11-13-2025
- Dividend Yield
- DSGN N/A
- STSS N/A
- EPS Growth
- DSGN N/A
- STSS N/A
- EPS
- DSGN N/A
- STSS N/A
- Revenue
- DSGN N/A
- STSS $222,722.00
- Revenue This Year
- DSGN N/A
- STSS N/A
- Revenue Next Year
- DSGN N/A
- STSS N/A
- P/E Ratio
- DSGN N/A
- STSS N/A
- Revenue Growth
- DSGN N/A
- STSS N/A
- 52 Week Low
- DSGN $2.60
- STSS $3.36
- 52 Week High
- DSGN $7.77
- STSS $1,248.27
- Technical
- Relative Strength Index (RSI)
- DSGN 54.51
- STSS 37.88
- Support Level
- DSGN $5.88
- STSS $6.42
- Resistance Level
- DSGN $7.59
- STSS $7.09
- Average True Range (ATR)
- DSGN 0.51
- STSS 0.49
- MACD
- DSGN -0.06
- STSS -0.15
- Stochastic Oscillator
- DSGN 37.42
- STSS 8.17
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.